Viewing nowIrbesartan 150 mg Tablet
Irbesartan 150mg
Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 200800335 · Notified 2008.01.08 · Insurance code 642704080
Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes
This medication is used to effectively manage high blood pressure. It is especially suitable for patients with essential hypertension and can also help prevent kidney disease in patients with Type 2 diabetes as part of a hypertension treatment regimen. Therefore, both blood pressure control and kidney function protection can be expected.
1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Patients with severe liver impairment or allergies to this medication should also avoid use. This drug contains lactose and is not suitable for patients with lactose intolerance or related genetic disorders. Diabetic patients with poor kidney function should not take this medication in combination with certain drugs. Elderly patients or patients with compromised liver function, heart disease, or kidney disease should use this medication with caution. This medication has blood pressure-lowering effects, which may cause symptoms of hypotension or dizziness, so caution is advised. Kidney function and serum potassium levels should be monitored through regular blood tests, as hyperkalemia may occur. Caution should be taken when taking it with other antihypertensive medications, diuretics, or potassium supplements due to potential interactions. Dizziness or fatigue may occur while driving or operating machinery, so caution is necessary. In cases of overdose, hypotension or arrhythmias may manifest, and immediate consultation with medical personnel is required. It is advisable to avoid use in children as safety and efficacy have not been established. If unusual symptoms occur during use, notify medical personnel immediately, especially if symptoms of angioedema such as swelling of the face, lips, or tongue appear, in which case use should be discontinued immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally in a cool, dry place below 30 degrees Celsius.
White or almost white, oval-shaped, biconvex tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrbesartan 150mg
Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.